Clark Henegan
@ClarkHenegan
Medical Oncologist with focus in prostate, bladder, kidney and testicular cancers. Tweets reflect my personal opinion.
Two opinions that to my surprise are either unpopular or not widely held: 1. The control arm of a randomised trial should be best standard of care. 2. A PFS benefit against an inactive comparator is not a major advance, if progressive disease is required for eligibility.
Survivor University provides resources to improve the quality of life of individuals facing cancer. In a recent expansion, the program is now open to all Mississippians, not just those treated at the University of Mississippi Medical Center. umc.edu/cancerinstitut… @rodrocconi
Honored to announce that I’ve accepted the role of Division Director of Hem/Onc and Associate Director for Clinical Affairs at the Cancer Center, University of Mississippi! Looking forward to contributing to the team’s growth and success this fall! #lcsm @UMMC_Cancer @rodrocconi
#ProstateCancer variants ✨Germline HOXB3 X285K variant: ⏩️risk factor in men of African ancestry ⏩️better response to ARPI @albertotm82 @clovis_fraga @OncoAlert @psalustiano @DrMourato @MSdoNascimento @Lfsala @anacardosomd @drdanielvargas @FabioSchutz @sandrocavallero…
Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant nature.com/articles/s4139… A recent discovery identified the germline HOXB13 X285K variant as a #ProstateCancer risk factor in men of African…
Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant. Longitudinal outcome analysis indicates that patients w this variant may have favorable responses to AR targeting therapy nature.com/articles/s4139…
Congratulations to Sharon Ezell, nurse practitioner in the Department of Radiation Oncology, for earning two prestigious oncology certifications—Oncology Certified Nurse and Advanced Oncology Certified Nurse Practitioner! Read more: umc.edu/cancerinstitut…
Tumor informed 🧬 #ctDNA #MRD high concordance with outcomes in #penileCA and #urethralCA , amazing work from rising 🌟 @KartikPatel___ @UABUrology working with @ccp1983 . @ONealCancerUAB @uabmedicine - so more to come from this group!
Check it out! Utility of ctDNA in locally advanced penile and urethral cancers. Bottom line, ctDNA correlates nicely with clinical response! Perhaps another tool for this uncommon disease. Best part, lead by a super-solid MS4 @KartikPatel___!! @UABUrology ascopubs.org/doi/10.1200/PO…
Congratulations to Dr. Rahat Noor for being name the School of Medicine Clinical Professor of the Year! Dr. Noor is one of the very best and has influenced many trainees in his time @UMMCnews ummcmedicinenews.org/2025/05/08/893…